Randomised Controlled TrialiVNSn = 707

Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial

Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, Milasinovic G, Berman BJ, Djordjevic S, Neelagaru S, et al.

Journal of the American College of Cardiology · 2016

Key finding

VNS did not reduce the rate of death or heart failure events, though secondary endpoints (quality of life, NYHA class, 6-minute walk) improved, suggesting the need for optimised stimulation parameters.

Condition
Heart Failure
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
707
View on DOI

Cite this study

Gold, M. R., Van Veldhuisen, D. J., Hauptman, P. J., Borggrefe, M., Kubo, S. H., Lieberman, R. A., Milasinovic, G., Berman, B. J., Djordjevic, S., Neelagaru, S., Schwartz, P. J., Starling, R. C., & Mann, D. L. (2016). Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial. Journal of the American College of Cardiology, 68(2), 149-158. https://doi.org/10.1016/j.jacc.2016.03.525

Related studies in Heart Failure

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.